← Open Payments lookup

CARL MCLEMORE: Open Payments

NPI 1073513941 · NEW ROADS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,538 in 95 payments from 25 companies in 2025. Trend: 2023 $1,288 · 2024 $1,360 · 2025 $1,538

Food & beverage: $1,538
CompanyPaymentsAmount
Lilly USA, LLC17$257
ABBVIE INC.20$217
Novo Nordisk Inc11$173
PFIZER INC.6$121
Abbott Laboratories5$97
GlaxoSmithKline, LLC.4$69
Otsuka America Pharmaceutical, Inc.3$66
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$63
Vanda Pharmaceuticals Inc.2$57
AstraZeneca Pharmaceuticals LP3$55

Products named: JARDIANCE, VRAYLAR, FREESTYLE LIBRE 3, Rybelsus, REXULTI, ELIQUIS, CAPLYTA, Ozempic.

Industry payments across LA — which companies pay providers there.